References
Longitudinal evaluation of serum values 2, 4, and 12 weeks after drug administration; group 1 (ferric carboxymaltose) presented in orange and group 2 (iron sucrose) presented in turquoise. 25(OH)D, 25-hydroxyvitamin D; CTX, beta-CrossLaps; Hb, hemoglobin; iPTH, intact parathyroid hormone; P1NP, procollagen type 1 amino-terminal propeptide. Data are presented as mean and 95% confidence intervals. * Demographic data and baseline blood values, group 1 (ferric carboxymaltose) and group 2 (iron sucrose).25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; CTX, beta-CrossLaps; Hb, hemoglobin; iPTH, intact parathyroid hormone; P1NP, procollagen type 1 amino-terminal propeptide. Data are presented as median and interquartile ranges Q1 and Q3.Longitudinal evaluation of serum values 2, 4, and 12 weeks after drug administration for group 1 (ferric carboxymaltose) and group 2 (iron sucrose).25(OH)D, 25-hydroxyvitamin D; CTX, beta-CrossLaps; Hb, hemoglobin; iPTH, intact parathyroid hormone; P1NP, procollagen type 1 amino-terminal propeptide. Data are presented as median and interquartile ranges Q1 and Q3. Significant values are marked in bold.